Rationale and design of the German-Speaking Myeloma Multicenter Group (GMMG) trial ReLApsE: a randomized, open, multicenter phase III trial of lenalidomide/dexamethasone versus lenalidomide/dexamethasone plus subsequent autologous stem cell transplantation and lenalidomide maintenance in patients with relapsed multiple myeloma

Baertsch, Marc-Andrea; Schlenzka, Jana; Mai, Elias K.; Merz, Maximilian; Hillengass, Jens; Raab, Marc S.; Hose, Dirk; Wuchter, Patrick; Ho, Anthony D.; Jauch, Anna; Hielscher, Thomas; Kunz, Christina; Luntz, Steffen; Klein, Stefan; Schmidt-Wolf, Ingo G. H.; Goerner, Martin; Schmidt-Hieber, Martin; Reimer, Peter; Graeven, Ullrich; Fenk, Roland; Salwender, Hans; Scheid, Christof; Nogai, Axel; Haenel, Mathias; Lindemann, Hans W.; Martin, Hans; Noppeney, Richard; Weisel, Katja; Goldschmidt, Hartmut

Rationale and design of the German-Speaking Myeloma Multicenter Group (GMMG) trial ReLApsE: a randomized, open, multicenter phase III trial of lenalidomide/dexamethasone versus lenalidomide/dexamethasone plus subsequent autologous stem cell transplantation and lenalidomide maintenance in patients with relapsed multiple myeloma

Author:

Baertsch, Marc-Andrea; Schlenzka, Jana; Mai, Elias K.; Merz, Maximilian; Hillengass, Jens; Raab, Marc S.; Hose, Dirk; Wuchter, Patrick; Ho, Anthony D.; Jauch, Anna; Hielscher, Thomas; Kunz, Christina; Luntz, Steffen; Klein, Stefan; Schmidt-Wolf, Ingo G. H.; Goerner, Martin; Schmidt-Hieber, Martin; Reimer, Peter; Graeven, Ullrich; Fenk, Roland; Salwender, Hans; Scheid, Christof; Nogai, Axel; Haenel, Mathias; Lindemann, Hans W.; Martin, Hans; Noppeney, Richard; Weisel, Katja; Goldschmidt, Hartmut

Tübinger Autor(en):

Weisel, Katja

Published in:

Bmc Cancer (2016), Bd. 16, Article 290

Verlagsangabe:

Biomed Central Ltd

Language:

English

Full text:

http://dx.doi.org/10.1186/s12885-016-2321-2

ISSN:

1471-2407